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Abstract 27 
Guidance from the National Institute for Health and Care Excellence (NICE) permits 28 
candidates to receive a cochlear implant provided they only hear sounds louder than 90 dB 29 
HL at 2 and 4 kHz. In some patients, their level of residual hearing may be sufficient to 30 
warrant the use of a hearing aid in their non-implanted ear. A survey of unilaterally-31 
implanted adults indicated that those implanted since the publication of NICE guidance were 32 
almost seven times more likely to use a hearing aid than those implanted prior to this. If 33 
contralateral hearing aid use provides additional benefits over implant use alone, it may be 34 
appropriate to consider the capacity to use residual hearing following implantation when 35 
determining candidacy. 36 
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Introduction 53 
Traditionally, cochlear implants (CIs) for adults in the UK were typically restricted to those  54 
with profound deafness, or little or no access to useful residual hearing (UKCISG 2004). 55 
They were therefore unlikely to benefit from the use of an acoustic hearing aid (HA) in their 56 
non-implanted ear following implantation. By the early 2000s, studies were emerging that 57 
demonstrated the capacity of cochlear implantation to provide benefit in patients with greater 58 
levels of residual hearing (Cullen et al., 2004; Dowell et al., 2004). Hearing preservation 59 
techniques were also being proposed to maximise the retention of residual hearing in the 60 
implanted ear (Lenarz et al., 2009). The publication of guidance from the National Institute 61 
for Health and Care Excellence (NICE 2009) formally expanded candidacy criteria in the UK 62 
to include adults with severe-to-profound hearing loss with some measurable residual hearing 63 
(up to 90 dB HL at 2 & 4 kHz) and open-set speech discrimination (less than 50% key words 64 
correct when presented in quiet).  65 
 66 
Notably,  NICE guidance places no restriction on low frequency hearing other than its 67 
capacity to support speech perception. Therefore, CI recipients in the UK may still have 68 
access to potentially useful and aidable low frequency hearing despite the restriction that 69 
NICE guidance places on their pre-operative speech perception abilities. Zhang et al (2010) 70 
demonstrated that low frequency information can still contribute to speech understanding 71 
when combined with a CI even if it is not sufficient to support open-set speech perception by 72 
itself. However, it is likely that obtaining benefit from the level of residual acoustic hearing 73 
available to UK candidates would require the use of a HA. It is possible, therefore, that NICE 74 
guidance may have increased the proportion of implant recipients who use a contralateral 75 
acoustic HA with their CI; i.e. who listen ‘bimodally’. 76 
 77 
The most recent large outcomes study in the UK was conducted before the publication of 78 
NICE guidance (UKCISG 2004). It is therefore unclear whether the combined effects of the 79 
guidance, the emerging evidence of the benefits of residual hearing, and the development of 80 
hearing preservation techniques in the late 2000s led to an increase in access to residual 81 
hearing among candidates and consequently to an increase in the use of contralateral acoustic 82 
HAs in the UK. A survey of adult unilateral CI users was conducted to establish whether 83 
those implanted since the publication of NICE guidance are more likely to use a HA in their 84 
non-implanted ear compared to those implanted in or prior to 2009. 85 
 86 
Methods 87 
A total of 623 surveys were sent to unilateral CI recipients at the Nottingham Adult Implant 88 
Programme and to 404 recipients at the Midlands Hearing Implant Programme. The inclusion 89 
criteria were: (1) 18 years or older; (2) unilateral CI recipient; (3) implanted in the UK. 90 
Eligible participants were given the option to return a paper survey or complete it online 91 
using Survey Monkey. The study was given a favourable opinion by the Health & Social 92 
Care Research Ethics Committee B (REC reference 15/NI/0054). 93 
 94 
Respondents were asked to indicate their age, which ear was implanted, the year of implant 95 
surgery (or the first surgery if they had been subsequently re-implanted), whether they were 96 
implanted in the UK, which was their better-hearing ear before surgery, and whether they 97 
currently use a HA in their non-implanted ear. Responses about which ear was implanted and 98 
which was perceived to be the better-hearing ear prior to implantation were used to classify 99 
patients into one of three sub-groups: (1) implanted in their worse ear; (2) implanted in their 100 
better ear; and (3) ear status prior to implantation similar or unknown. The proportion of HA 101 
users was established in each sub-group and 95% confidence intervals were calculated using 102 
Wilson’s procedure (Newcombe, 1998). 103 
 104 
Respondents were divided into two categories: those who were implanted prior to the 105 
publication of NICE guidance, and those who were implanted since. Binary logistic 106 
regression established whether patients implanted since were more likely to use a HA than 107 
those implanted before NICE. The regression model controlled for the age at time of survey 108 
completion as HA usage would be expected to decline with age as any residual hearing 109 
deteriorates and those implanted before NICE were likely to have been older than those 110 
implanted since. The model also controlled for whether patients were implanted in what they 111 
considered to be their better or worse ear as those implanted in their better ear may have been 112 
less likely to wear a HA contralaterally. Missing data was found to constitute less than 5% of 113 
the data across all variables (year of implantation, HA usage, age, better ear prior to 114 
implantation) and was treated as missing at random. Rather than excluding those cases, 115 
missing data from a patient on any one variable was accounted for by estimating (imputing) 116 
the value that would have been most likely given their values on the other variables; i.e. 117 
multivariate imputation. Fifty imputations by chained equations were conducted using the 118 
‘mice’ package in the R statistical programming environment (van Buuren and Groothuis-119 
Oudshoorn, 2011). The overall regression model comparing HA usage rates before and after 120 
NICE was run both with and without imputation to confirm that the pattern of effects was not 121 
driven by the use of this procedure.  122 
 123 
 124 
Results 125 
In total, 314 paper responses and 44 online responses were received representing a response 126 
rate of 35%. One respondent was excluded on the basis of age (under 18 years) and four on 127 
the basis of their country of implantation (outside the UK). Table 1 contains a summary of 128 
the remaining 353 responses. Forty-three percent of respondents received their implant in the 129 
six years since NICE guidance, 23% in the preceding six years between 2004 and 2009, with 130 
the remainder having been implanted in the 19 years between 1985 and 2003. Almost one 131 
third of all respondents reported using a contralateral HA and nearly 60% recalled having a 132 
better-hearing ear prior to implantation. 133 
 134 
---------------------------- 135 
Table 1 here 136 
---------------------------- 137 
 138 
Figure 1 shows the proportion of reported contralateral HA users separately for those 139 
implanted before and after the publication of NICE guidance. Across the whole sample, HA 140 
use was found to increase by 34.3% from a pre-NICE score of 13.3% to a post-NICE score of 141 
47.6% (𝜒2(1)=45.1, p<.001). A significant increase in HA use was apparent in all three sub-142 
groups with the largest increase observed among those who reported being implanted in their 143 
worse ear (40.3% increase to 56.7% from 16.4%, 𝜒2(1)=38.4, p<.001). 144 
 145 
---------------------------- 146 
Figure 1 here 147 
---------------------------- 148 
 149 
To assess whether HA use increased gradually over time or abruptly following the 150 
publication of NICE guidance, the proportion of reported contralateral HA users was 151 
calculated for all those who were implanted within consecutive 3-year periods between 2004 152 
and 2015 (Figure 2). A similar proportion of contralateral HA users was observed amongst 153 
those implanted in 2004-6 (22.2%) and 2007-9 (18.5%; 𝜒2(1)=0.01, p=.54). The proportion of 154 
HA users then increased significantly amongst those implanted in 2010-12 (37.7%; 155 𝜒2(1)=4.3, p<.05), and increased further in the most recent period from 2013-15 (54.5%; 156 𝜒2(1)=3.4, p<.05). 157 
 158 
---------------------------- 159 
Figure 2 here 160 
---------------------------- 161 
 162 
The logistic regression model indicated that reported HA use was almost three times more 163 
likely among those who indicated that they were implanted in their worse ear compared to 164 
those implanted in their better ear (OR=2.9, 95% confidence interval 1.5 to 5.6). No 165 
significant influence of age was observed (𝜒2(4)=4.8, p=.31). After controlling for these 166 
factors, the regression model indicated that patients implanted in the six years since the 167 
publication of NICE guidance were almost seven times more likely to use a HA than those 168 
implanted anytime between 1985 and 2009 (OR=6.7, 95% confidence interval 3.6 to 12.3) 169 
and almost four times more likely than those implanted in the six years immediately 170 
preceding the publication of the guidance (2004 to 2009, OR=3.69, 95% confidence interval 171 
1.82 to 7.47).  172 
 173 
 174 
 175 
Discussion 176 
It is possible that the reported HA use rates of around 30% across all respondents and 48% 177 
across those implanted since NICE may be over-estimates. Some HA non-users may have 178 
decided that the survey was not applicable to them even though the survey was sent to CI 179 
recipients regardless of whether they used a HA or not and the supporting information clearly 180 
stated that we also wished to hear from those who do not use a HA. Additionally, the number 181 
of respondents implanted since NICE guidance was almost as numerous as those implanted 182 
before (43% and 51% respectively with 6% missing data) despite only six years having 183 
elapsed since its publication. Therefore, the survey respondents may have been self-selecting 184 
on the basis of HA use. Nevertheless, the results would seem to suggest that HA use has 185 
increased substantially since NICE guidance and confirm that there may be at least 100 186 
‘bimodally-aided’ listeners across just two UK implant programmes. 187 
 188 
Although the proportion of implant recipients who reported using a contralateral HA 189 
increased significantly around the time that NICE guidance was published (Figure 2), it is 190 
unclear whether this increase can be solely attributed to the guidance alone. Research 191 
outlining the potential benefits of implanting candidates with greater levels of residual 192 
hearing (Dowell et al., 2004) and advances in hearing preservation techniques to minimise 193 
the risk of irreversible damage from implantation (Lenarz et al., 2009) were being published 194 
around the same time. However, it seems plausible that the observed effect on HA use among 195 
UK implant recipients can be attributed, at least in part, to the publication of the NICE 196 
guidance that likely led to changes in referral patterns and consequently greater levels of 197 
residual hearing in contemporary candidates for implantation. 198 
 199 
Recent evidence suggests that some UK patients can derive benefits from the combined use 200 
of a CI and a HA (Visram et al, 2012; Green et al, 2014). However, the reasons why such a 201 
relatively large proportion of recent CI recipients continue to use a contralateral HA despite 202 
their limited access to residual hearing remain largely unclear. Only if characterised through 203 
further research would it then be possible to examine how those specific benefits could be 204 
optimised when fitting one or both devices. Should further evidence emerge that this 205 
‘bimodal’ listening configuration provides additional benefits over implant use alone, it may 206 
be appropriate to consider the potential for a patient to continue to use their residual hearing 207 
following implantation when determining candidacy. 208 
 209 
Despite the apparent increase in the number of bimodally-aided patients suggested by the 210 
current results, clinical practice does not appear to have adapted its focus away from 211 
maximising benefit from use of the CI alone. A recent survey of UK audiologists working 212 
across adult implant programmes suggested that both devices are still typically maintained by 213 
two separate service providers (Fielden and Kitterick, 2015). Thus, further research is still 214 
required to explore how the provision of services could be adapted to support and manage the 215 
effective use of both devices. 216 
 217 
Conclusion 218 
Since the publication of the NICE guidance in 2009, there has been a significant increase in 219 
reported contralateral HA use among adult unilateral CI users. As a result, there may now be 220 
many more CI users who benefit from simultaneous access to electric and acoustic 221 
information. It may therefore be appropriate to consider a patient’s capacity to exploit their 222 
residual hearing following implantation when assessing candidacy for implantation. 223 
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Legends 264 
Figure 1. Proportion of reported contralateral hearing aid users across the whole sample (‘All 265 
patients’) and within sub-groups identified by whether they were implanted in their worse 266 
ear, their better ear, or did not report having a better ear prior to implantation 267 
(‘Same/Unknown’). Error bars plot the 95% confidence intervals for the proportions. 268 
Asterisks indicate the result of comparing the proportions using Wilson’s test, *** p<.001, ** 269 
p<.01.  270 
 271 
Figure 2. Proportion of reported contralateral hearing aid users in the 6 years immediately 272 
pre- and post- NICE guidance, divided into 3-year time bins. Error bars plot the 95% 273 
confidence intervals for the proportions. Asterisks indicate the result of comparing the 274 
proportions using Wilson’s test, *** p<.001, * p<.05.  275 
 276 
Table 1. Summary statistics of the 353 respondents whose data were included in the analysis. 277 
In cases where an ear had been re-implanted, the year of the first implantation was taken as 278 
the year of surgery. 279 
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